ClinicalTrialsFinder

Sub-study 2 Head and Neck Squamous Cell Carcinoma (Volrustomig Monotherapy) Clinical Trials in Edmonton, Alberta

1 recruitingEdmonton, Alberta, Canada

Showing 1–1 of 1 trials

Recruiting
Phase 2

Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors

Sub-study 1 Cervical Cancer (Volrustomig Monotherapy)Sub-study 2 Head and Neck Squamous Cell Carcinoma (Volrustomig Monotherapy)Sub-study 3 Head and Neck Squamous Cell Carcinoma (Volrustomig in Combination With Chemotherapy)+2 more
AstraZeneca257 enrolled95 locationsNCT06535607